Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27318593 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL31484796 | 1.00 | LMNA (0.61) | — | |
| SCHEMBL13169650 | 0.97 | — | — | |
| SCHEMBL12140935 | 0.97 | — | — | |
| SCHEMBL2148 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL2760794 | 0.94 | — | — | |
| SCHEMBL410923 | 0.94 | — | — | |
| SCHEMBL20641496 | 0.94 | — | — | |
| SCHEMBL4649402 | 0.94 | — | — | |
| SCHEMBL14656141 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6793 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105133-A1 | TNF- Α AND IL-17 INHIBITOR COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES | DAMLE LATHA (IN) | 2026-05-21 | — | — | WO | claimed |
| US-12478615-B2 | Prolyl hydroxylase inhibitors and methods of use | AKEBIA THERAPEUTICS, INC. (US) | 2025-11-25 | — | — | US | claimed |
| CN-116472266-B | Compounds as prolyl hydroxylase inhibitors and methods of making the same | 苏中药业集团股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120022522-A | Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system | 成都邦迈医创科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-120004758-A | Screening and verifying method of targeting sclerostin specific structural domain small molecule inhibitor | 中山大学 | 2025-05-16 | — | — | CN | claimed |
| CN-119979110-A | Hydrophilic adhesive based on lipoic acid derivative sodium salt and preparation and debonding methods thereof | 华东理工大学 | 2025-05-13 | — | — | CN | claimed |
| CN-115521328-B | Organic boron fluorescent material and preparation method and application thereof | 河南农业大学 | 2025-03-21 | — | — | CN | claimed |
| CN-115109006-B | Preparation method of 3-substituted-1, 2-benzoxazine-4-ketone compound | 上海大学 | 2025-03-14 | — | — | CN | claimed |
| CN-119591644-A | Key material for preparing flame-retardant and light-resistant core-shell type water-based acrylic resin coating | 烟台大学 | 2025-03-11 | — | — | CN | claimed |
| CN-119530330-A | Protein-like modified edible peptide for promoting bone action and preparation method thereof | 海南经贸职业技术学院 | 2025-02-28 | — | — | CN | claimed |
| US-6436834-B1 | ABRASION ACCELERATOR ENHANCES THE REMOVAL RATE OF A DIELECTRIC LAYER BY CHELATION IN EITHER AN ACIDIC OR A BASIC MEDIUM; METHYL GLYCINATE, GLYCINAMIDE, AMINOGUANIDINE, SEMICARBAZIDE, GUANIDINE, UREA, FORMAMIDINE, ACETAMIDINE, FORMAMIDE, | ETERNAL CHEMICAL CO., LTD. (TW) | 2002-08-20 | — | — | US | claimed |
| CN-1282775-A | chemical mechanical polishing composition and method | CHANGXING CHEMICAL INDUSTRY CO (CN) | 2001-02-07 | — | — | CN | claimed |
| EP-1072662-A1 | Chemical-mechanical abrasive composition and method | Eternal Chemical Co., Ltd. (TW) | 2001-01-31 | — | — | EP | claimed |
| US-5801011-A | Process for preparing cephalosporins with penicillin acylase without pH control | ELI LILLY AND COMPANY (US) | 1998-09-01 | — | — | US | claimed |
| EP-0500653-A4 | INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE | BIOCRYST INC (US) | 1995-08-23 | — | — | EP | claimed |
| EP-0638080-A4 | 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME. | BIOCRYST PHARM INC (US) | 1995-08-23 | — | — | EP | claimed |
| EP-0638080-A1 | 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME | BIOCRYST PHARMACEUTICALS, INC. (US) | 1995-02-15 | — | — | EP | claimed |
| WO-1993021187-A1 | 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME | BIOCRYST PHARMACEUTICALS, INC. (US) | 1993-10-28 | — | — | WO | claimed |
| EP-0500653-A1 | INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE | BIOCRYST PHARMACEUTICALS INC. (US) | 1992-09-02 | — | — | EP | claimed |
| WO-1991006548-A1 | INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE | BIOCRYST, INC. (US) | 1991-05-16 | — | — | WO | claimed |